Deal Summary
Concise recitation of parties, consideration, security type, and closing amounts to avoid ambiguity in financial commitments and issuer obligations.
A dated, detailed investment and transaction agreement fixes the timing of rights and obligations, clarifies closing mechanics, preserves evidence of negotiated terms, and reduces post-closing disputes by memorializing representations, conditions and indemnities in a single record.
Each participant relies on the dated agreement to trigger performance obligations, satisfy regulatory checks, and establish remedies if closing conditions are unmet.
Chief Investment Officer or authorized signatory who executes on behalf of an investing entity; typically has board authorization and may sign subject to fund-level approvals and wire-transfer instructions. Confirm authority with corporate resolution before closing.
CEO, CFO, or other officer authorized by board resolution to bind the company and provide representations and warranties. They coordinate delivery of closing certificates, officer certificates, and any required third-party consents.
Concise recitation of parties, consideration, security type, and closing amounts to avoid ambiguity in financial commitments and issuer obligations.
Detailed seller and buyer representations covering organization, authority, financial statements, material contracts, and regulatory compliance to allocate risk.
Specified deliverables and approvals required on the effective date such as consents, officer certificates, and absence of material adverse change.
Pre- and post-closing promises, including conduct of business covenants, non-compete or non-solicit clauses, and information rights.
Scope, survival periods, caps, and procedures for claims and defenses to manage post-closing liability and recovery.
Wire instructions, escrow arrangements, signature blocks, notary requirements, and steps for delivering closing deliverables and certificates.
| Field | Configuration |
|---|---|
| Signing Order | Sequential signers in required sequence |
| Authentication | Email + SMS code or stronger as needed |
| Conditional Fields | Show or hide based on answers |
| Audit Trail | Enable IP, timestamp, and action logs |
Ensure the chosen platform provides ESIGN/UETA compliance, record retention, and role-based access; coordinate any HIPAA or 21 CFR Part 11 requirements before routing patient or FDA-regulated records.
Date printed in the agreement; starts obligations.
Deadline for signatures to satisfy conditions precedent.
Date by which funds must be wired to close.
Securities or governmental notices due post-closing.
Claims survival defined; begins on closing or effective date.
Obtain consents, deliver certificates, and confirm no material adverse change.
Investor wires purchase funds into escrow or to company account.
Deliver stock certificates, assignment instruments, and releases.
File required notices, amend cap table, and update registries.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies | Varies | Varies | Varies |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies | Varies | Varies |
Optica standardized closing packages to reduce back-and-forth during fundraising
Xerox integrated executed agreements with their ERP to automate post-closing entries